Medicare Advantage Beneficiary Enrollment Decisions Following New Complex Conditions.

IF 12.5 Q1 HEALTH CARE SCIENCES & SERVICES
Mark K Meiselbach, Jianhui Xu, Teneil Brown, Daniel Polsky
{"title":"Medicare Advantage Beneficiary Enrollment Decisions Following New Complex Conditions.","authors":"Mark K Meiselbach, Jianhui Xu, Teneil Brown, Daniel Polsky","doi":"10.1001/jamahealthforum.2026.2843","DOIUrl":null,"url":null,"abstract":"<p><strong>Importance: </strong>Prior research has demonstrated higher rates of disenrollment from Medicare Advantage (MA) among people with greater health care needs. Yet, less is known about how disenrollment responds to changes in medical complexity, whether disenrollment varies by the degree of complexity, and how these patterns differ by state Medigap protections and MA plan characteristics.</p><p><strong>Objective: </strong>To examine changes in MA plan disenrollment following the development of new complex medical conditions and assess heterogeneity by number of conditions, state Medigap policy, and plan characteristics.</p><p><strong>Design, setting, and participants: </strong>This cohort study used Medicare enrollment and claims data from 2016 to 2021. The study population included beneficiaries continuously enrolled in MA in 2016 without complex medical conditions from 2016 through 2018. A treatment group developed a new complex condition in 2019; a comparison group did not develop a complex condition through 2021. Data were analyzed from December 1, 2025, to March 1, 2026.</p><p><strong>Exposure: </strong>Development of 1 or more new complex medical conditions in 2019, including acute myocardial infarction, Alzheimer disease and related dementia, atrial fibrillation, chronic kidney disease, chronic obstructive pulmonary disease, depression, congestive heart failure, or stroke.</p><p><strong>Main outcomes and measures: </strong>Annual disenrollment from the prior year MA plan, which included disenrollment to traditional Medicare (TM) or switching to another plan within MA. Difference-in-differences models with beneficiary and year fixed effects were estimated and converted to differences in percentage points.</p><p><strong>Results: </strong>The analytic sample included 1 054 926 beneficiaries, including 219 942 (mean [SD] age, 75.3 [6.3] years; 54.6% female) who developed new complex conditions in 2019 and 834 984 (mean [SD] age, 73.8 [5.6] years; 56.7% female) who did not develop a new complex condition in 2019. Developing any new complex condition was associated with an increase of 3.3 (95% CI, 3.1-3.5) percentage points (pp) in MA disenrollment, including an increase of 2.8 (95% CI, 2.7-2.9) pp in disenrollment to TM. The number of new complex conditions was associated with increased disenrollment, from 1.4 (95% CI, 1.3-1.6) pp for 1 condition to 12.8 (95% CI, 11.6-13.9) pp for 4 or more conditions. Disenrollment to TM was 1.5 (95% CI, 0.9-2.1) pp higher among beneficiaries residing in states with Medigap guaranteed issue and community rating protections.</p><p><strong>Conclusions and relevance: </strong>In this study, development of new complex medical conditions was associated with higher MA disenrollment, particularly to TM and in states with Medigap protections, and the magnitude increased with medical complexity. These findings highlight how changes in health status and state policy may shape Medicare coverage decisions.</p>","PeriodicalId":53180,"journal":{"name":"JAMA Health Forum","volume":"7 8","pages":"e262843"},"PeriodicalIF":12.5000,"publicationDate":"2026-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13499002/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JAMA Health Forum","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1001/jamahealthforum.2026.2843","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Importance: Prior research has demonstrated higher rates of disenrollment from Medicare Advantage (MA) among people with greater health care needs. Yet, less is known about how disenrollment responds to changes in medical complexity, whether disenrollment varies by the degree of complexity, and how these patterns differ by state Medigap protections and MA plan characteristics.

Objective: To examine changes in MA plan disenrollment following the development of new complex medical conditions and assess heterogeneity by number of conditions, state Medigap policy, and plan characteristics.

Design, setting, and participants: This cohort study used Medicare enrollment and claims data from 2016 to 2021. The study population included beneficiaries continuously enrolled in MA in 2016 without complex medical conditions from 2016 through 2018. A treatment group developed a new complex condition in 2019; a comparison group did not develop a complex condition through 2021. Data were analyzed from December 1, 2025, to March 1, 2026.

Exposure: Development of 1 or more new complex medical conditions in 2019, including acute myocardial infarction, Alzheimer disease and related dementia, atrial fibrillation, chronic kidney disease, chronic obstructive pulmonary disease, depression, congestive heart failure, or stroke.

Main outcomes and measures: Annual disenrollment from the prior year MA plan, which included disenrollment to traditional Medicare (TM) or switching to another plan within MA. Difference-in-differences models with beneficiary and year fixed effects were estimated and converted to differences in percentage points.

Results: The analytic sample included 1 054 926 beneficiaries, including 219 942 (mean [SD] age, 75.3 [6.3] years; 54.6% female) who developed new complex conditions in 2019 and 834 984 (mean [SD] age, 73.8 [5.6] years; 56.7% female) who did not develop a new complex condition in 2019. Developing any new complex condition was associated with an increase of 3.3 (95% CI, 3.1-3.5) percentage points (pp) in MA disenrollment, including an increase of 2.8 (95% CI, 2.7-2.9) pp in disenrollment to TM. The number of new complex conditions was associated with increased disenrollment, from 1.4 (95% CI, 1.3-1.6) pp for 1 condition to 12.8 (95% CI, 11.6-13.9) pp for 4 or more conditions. Disenrollment to TM was 1.5 (95% CI, 0.9-2.1) pp higher among beneficiaries residing in states with Medigap guaranteed issue and community rating protections.

Conclusions and relevance: In this study, development of new complex medical conditions was associated with higher MA disenrollment, particularly to TM and in states with Medigap protections, and the magnitude increased with medical complexity. These findings highlight how changes in health status and state policy may shape Medicare coverage decisions.

新的复杂条件下的医疗保险优势受益人登记决定。
重要性:先前的研究表明,在医疗保健需求较大的人群中,从医疗保险优势(MA)退出的比率较高。然而,关于取消登记如何应对医疗复杂性的变化,取消登记是否因复杂程度而异,以及这些模式如何因州医疗保险保护和MA计划特征而异,我们所知甚少。目的:研究新的复杂医疗状况发生后MA计划退出的变化,并通过疾病数量、国家医疗保险政策和计划特征评估异质性。设计、环境和参与者:本队列研究使用了2016年至2021年的医疗保险登记和索赔数据。研究人群包括2016年至2018年期间连续参加MA的受益人,没有复杂的医疗状况。一个治疗组在2019年出现了新的复杂疾病;到2021年,对照组没有出现复杂的症状。数据分析时间为2025年12月1日至2026年3月1日。暴露:2019年出现1种或更多新的复杂疾病,包括急性心肌梗死、阿尔茨海默病和相关痴呆、心房颤动、慢性肾病、慢性阻塞性肺病、抑郁症、充血性心力衰竭或中风。主要结果和措施:每年从上一年的MA计划中退出,包括退出传统医疗保险(TM)或切换到MA中的另一个计划。对受益人和年份固定效应的差异中差异模型进行了估计,并转换为百分点差异。结果:分析样本包括1 054 926名受益人,其中219 942人(平均[SD]年龄,75.3[6.3]岁,女性54.6%)在2019年出现新的复杂疾病,834 984人(平均[SD]年龄,73.8[5.6]岁,女性56.7%)在2019年没有出现新的复杂疾病。发生任何新的复杂疾病与MA退入增加3.3 (95% CI, 3.1-3.5)个百分点(pp)相关,包括TM退入增加2.8 (95% CI, 2.7-2.9)个百分点。新的复杂条件的数量与退入增加相关,从1个条件的1.4 (95% CI, 1.3-1.6)个pp到4个或更多条件的12.8 (95% CI, 11.6-13.9)个pp。居住在有医疗保险保障发行和社区评级保护的州的受益人退出TM的概率高出1.5 (95% CI, 0.9-2.1)个百分点。结论和相关性:在本研究中,新的复杂医疗状况的发展与更高的MA退保率相关,特别是TM和有医疗保险保护的州,且退保率随医疗复杂性的增加而增加。这些发现强调了健康状况和国家政策的变化如何影响医疗保险覆盖的决定。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.00
自引率
7.80%
发文量
0
期刊介绍: JAMA Health Forum is an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health, and health care. The journal publishes original research, evidence-based reports, and opinion about national and global health policy. It covers innovative approaches to health care delivery and health care economics, access, quality, safety, equity, and reform. In addition to publishing articles, JAMA Health Forum also features commentary from health policy leaders on the JAMA Forum. It covers news briefs on major reports released by government agencies, foundations, health policy think tanks, and other policy-focused organizations. JAMA Health Forum is a member of the JAMA Network, which is a consortium of peer-reviewed, general medical and specialty publications. The journal presents curated health policy content from across the JAMA Network, including journals such as JAMA and JAMA Internal Medicine.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书